Less Ads, More Data, More Tools Register for FREE

Monday broker round-up

Mon, 11th Jun 2012 09:37
Antofagasta: RBS Capital Markets downgrades to underperform.Ashtead: Jefferies keeps buy recommendation and 300p target.Barclays: Bank of America Merrill Lynch keeps buy rating and 370p target; Oriel Securities reiterates buy recommendation and 285p target.BP: Nomura retains neutral stance and 500p target.Craneware: Investec upgrades from hold to buy, target cut from 405p to 390p.ENRC: RBC Capital Markets downgrades to underperform.Flybe: Investec ups target from 70p to 89p, hold rating kept; Oriel Securities reiterates reduce recommendation.GlaxoSmithKline: Credit Suisse keeps neutral rating and 1,430p target.Helical Bar: Oriel Securities upgrades to buy.HSBC: Oriel Securities reiterates reduce recommendation and 550p target.International Consolidated Airlines Group: Nomura maintains buy rating and 265p target.Johnson Matthey: Numis downgrades to add. target cut from 2,660p to 2,664p.Lamprell: Investec slashes target from 200p to 100p, hold rating kept.Lloyds: Oriel Securities reiterates buy recommendation and 45p target.Royal Bank of Scotland: Oriel Securities reiterates buy recommendation and 40p target.Serco: Investec reiterates buy recommendation and 620p target; Oriel Securities reiterates reduce recommendation and 500p target.Smiths Group: Jefferies maintains buy rating and 1,600p target.Standard Chartered: Oriel Securities reiterates buy recommendation and 1,900p target.Tate & Lyle: Societe General upgrades to hold.Tesco: Nomura reiterates buy rating and 430p target; Oriel Securities reiterates reduce recommendation and 280p target; Credit Suisse keeps neutral rating and 370p target.WH Smith: Nomura keeps buy recommendation and 600p target.BC International Airlines Tesco Barclays Lloyds Wh Smith HSBC Holdings Helical Bar Tate & Lyle Johnson Matthey Standard Chartered Serco Craneware Smiths Group Glaxosmithkline Antofagasta

Shares in this article

Related News

GSK says US FDA approves urinary tract infection treatment Utebzi
8 hours ago

GSK says US FDA approves urinary tract infection treatment Utebzi

(Alliance News) - GSK PLC and Spero Therapeutics Inc on Wednesday said that the US Food & Drug Administration has approved Utebzi, an oral antibiotic ...

LONDON MARKET CLOSE: FTSE 100 nudges up ahead of expected US rate hold
13 hours ago

LONDON MARKET CLOSE: FTSE 100 nudges up ahead of expected US rate hold

(Alliance News) - Stocks posted modest gained on Wednesday, after better-than-hoped inflation data, and as investors eye interest rate decisions in th...

Market News Endeavour Mining + 12 more shares
Huawei CFO's admissions can be used against company at criminal trial, US judge rules
13 hours ago

Huawei CFO's admissions can be used against company at criminal trial, US judge rules

* Meng acknowledged Huawei's business in Iran as part of 2021 agreement ​to drop ⁠charges against her